scispace - formally typeset
T

Thomas Martin

Researcher at University of California, San Francisco

Publications -  311
Citations -  17918

Thomas Martin is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Medicine & Exocytosis. The author has an hindex of 73, co-authored 242 publications receiving 15771 citations. Previous affiliations of Thomas Martin include Institut national de la recherche agronomique & University of Western Australia.

Papers
More filters
Journal ArticleDOI

Multiple myeloma, version 1.2020 featured updates to the NCCN guidelines

TL;DR: The NCCN Guidelines for Multiple Myeloma as mentioned in this paper provide recommendations for diagnosis, workup, treatment, follow-up, and supportive care for patients with monoclonal gammopathy of renal significance.
Journal ArticleDOI

PI(4,5)P2-binding effector proteins for vesicle exocytosis

TL;DR: Overall, focal vesicle exocytosis occurs at sites landmarked by PI(4,5)P2, which serves to recruit and/or activate multifunctional PI( 4, 5)P₂-binding proteins.
Journal ArticleDOI

Protein kinase C translocates from cytosol to membrane upon hormone activation: effects of thyrotropin-releasing hormone in GH3 cells.

TL;DR: Results provide evidence for the concept that cell-surface receptor-mediated phosphoinositide breakdown activates protein kinase C and translocation of PK C to the membrane is an early step in the cellular activation of this enzyme.
Journal ArticleDOI

A family of Ca2+-dependent activator proteins for secretion: comparative analysis of structure, expression, localization, and function.

TL;DR: Differences in the spatial and temporal expression patterns of the two CAPS isoforms most likely reflect as yet unidentified subtle functional differences required in particular cell types or during a particular developmental period.
Journal ArticleDOI

3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer: A pilot study

TL;DR: Pilot study to evaluate feasibility, acute toxicity and conformal quality of 3D conformal high-dose-rate (HDR) brachytherapy as a monotherapy for localized prostate cancer using intraoperative real-time planning is presented in this article.